Simplicity Wealth’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Simplicity Wealth's BIIB Position: Q2 2026 in Review
Simplicity Wealth increased its Biogen (BIIB) stake by 5.1% in Q2 2026, buying an estimated $21K and bringing the position to 2,259 shares worth $488K. The position accounts for 0.02% of the portfolio, ranked #650.
Simplicity Wealth first reported a position in BIIB in Q1 2024 and has held it in 7 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Simplicity Wealth held 2,259 shares of Biogen worth $488K as of Q2 2026.
- Simplicity Wealth bought 110 Biogen shares in Q2 2026, an estimated $21K.
- Biogen made up 0.02% of Simplicity Wealth's portfolio in Q2 2026, its #650 holding.
- Simplicity Wealth first reported a position in Biogen in Q1 2024 and has held it in 7 quarters since.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Simplicity Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.